---
title: A review of clinical guidelines, laboratory recommendations and external quality
  assurance program for monoclonal gammopathy testing
date: '2023-09-30'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37776896/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20231001180753&v=2.17.9.post6+86293ac
source: heidelberg[Affiliation]
description: Monoclonal gammopathy (MG) is a spectrum of diseases ranging from the
  benign asymptomatic monoclonal gammopathy of undetermined significance to the malignant
  multiple myeloma. Clinical guidelines and laboratory recommendations have been developed
  to inform best practices in the diagnosis, monitoring, and management of MG. In
  this review, the pathophysiology, relevant laboratory testing recommended in clinical
  practice guidelines and laboratory recommendations related to MG testing and ...
disable_comments: true
---
Monoclonal gammopathy (MG) is a spectrum of diseases ranging from the benign asymptomatic monoclonal gammopathy of undetermined significance to the malignant multiple myeloma. Clinical guidelines and laboratory recommendations have been developed to inform best practices in the diagnosis, monitoring, and management of MG. In this review, the pathophysiology, relevant laboratory testing recommended in clinical practice guidelines and laboratory recommendations related to MG testing and ...